Drug Profile
Iodofiltic acid I-123 - Medco Research
Alternative Names: Iodophenylpentadecanoic acid I-123; ViaScintLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator King Pharmaceuticals Research and Development
- Class Fatty acids; Imaging agents; Iodinated contrast media; Iodobenzenes; Small molecules
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Coronary disorders
Most Recent Events
- 12 Apr 1999 Discontinued - Preregistration for Coronary disorders diagnosis in USA (unspecified route)
- 22 Nov 1996 Preregistration for Coronary disorders diagnosis in USA (unspecified route)